Proposing low-similarity peptide vaccines against mycobacterium tuberculosis

Journal of Biomedicine and Biotechnology

Volumn 2010, Issue , 2010, Pages

  Kanduc, Darja ^a   Lucchese, Guglielmo ^a   Stufano, Angela ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; EPITOPE; PEPTIDE VACCINE; PROTEOME; BCG VACCINE; SUBUNIT VACCINE;

AMINO ACID SEQUENCE; ARTICLE; HUMAN; HYPOTHESIS; IMMUNE RESPONSE; IMMUNOGENICITY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PROTEIN DOMAIN; PROTEIN MOTIF; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; T LYMPHOCYTE; TUBERCULOSIS; VACCINATION; AMINO ACID SUBSTITUTION; CHEMISTRY; GENETICS; IMMUNOLOGY; MOLECULAR GENETICS;

BACTERIA (MICROORGANISMS); MYCOBACTERIUM TUBERCULOSIS;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; EPITOPES, B-LYMPHOCYTE; EPITOPES, T-LYMPHOCYTE; HUMANS; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM TUBERCULOSIS; PROTEOME; SEQUENCE HOMOLOGY, AMINO ACID; TUBERCULOSIS VACCINES; VACCINES, SUBUNIT;

EID: 77954553347     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2010/832341     Document Type: Article

References (74)

1. Corbett E. L., Watt C. J., Walker N., The growing burden of tuberculosis: global trends and interactions with the HIV epidemic Archives of Internal Medicine 2003 163 9 1009 1021
2. The World Health Organization Report, Global Tuberculosis Control 2009 Geneva, Switzerland WHO
3. Fine P. E. M., BCG: the challenge continues Scandinavian Journal of Infectious Diseases 2001 33 4 243 245
4. Huygen K., DNA vaccines against mycobacterial diseases Future Microbiology 2006 1 63 73
5. Tanghe A., Dangy J.-P., Pluschke G., Huygen K., Improved protective efficacy of a species-specific DNA vaccine encoding mycolyl-transferase Ag85A from Mycobacterium ulcerans by homologous protein boosting PLoS Neglected Tropical Diseases 2008 2 3, article e199
6. Meya D. B., McAdam K. P., The TB pandemic: an old problem seeking new solutions Journal of Internal Medicine 2007 261 4 309 329
7. Nissapatorn V., Kuppusamy I., Josephine F. P., Jamaiah I., Rohela M., Khairul Anuar A., Tuberculosis: a resurgent disease in immunosuppressed patients The Southeast Asian Journal of Tropical Medicine and Public Health 2006 37 supplement 3 153 160
8. Abebe F., Bjune G., The protective role of antibody responses during Mycobacterium tuberculosis infection Clinical and Experimental Immunology 2009 157 2 235 243
9. Xu Y., Zhu B., Wang Q., Recombinant BCG coexpressing Ag85B, ESAT-6 and mouse-IFN- confers effective protection against Mycobacterium tuberculosis in C57BL/6 mice FEMS Immunology and Medical Microbiology 2007 51 3 480 487
10. Qie Y. Q., Wang J. L., Zhu B. D., Evaluation of a new recombinant BCG which contains mycobacterial antigen ag85B-mpt64190-198-mtb8.4 in C57/BL6 mice Scandinavian Journal of Immunology 2008 67 2 133 139
11. Chang-Hong S., Xiao-Wu W., Hai Z., Ting-Fen Z., Li-Mei W., Zhi-Kai X., Immune responses and protective efficacy of the gene vaccine expressing Ag85B and ESAT6 fusion protein from Mycobacterium tuberculosis DNA and Cell Biology 2008 27 4 199 207
12. Hussain R., Dockrell H. M., Chiang T. J., Dominant recognition of a cross-reactive B-cell epitope in Mycobacterium leprae 10K antigen by immunoglobulin G1 antibodies across the disease spectrum in leprosy Immunology 1999 96 4 620 627
13. Singh K. K., Sharma N., Vargas D., Peptides of a novel Mycobacterium tuberculosis -specific cell wall protein for immunodiagnosis of tuberculosis Journal of Infectious Diseases 2009 200 4 571 581
14. Baassi L., Sadki K., Seghrouchni F., Evaluation of a multi-antigen test based on B-cell epitope peptides for the serodiagnosis of pulmonary tuberculosis International Journal of Tuberculosis and Lung Disease 2009 13 7 848 854
15. Gowthaman U., Agrewala J. N., In silico tools for predicting peptides binding to HLA-class II molecules: more confusion than conclusion Journal of Proteome Research 2008 7 1 154 163
16. Blythe M. J., Flower D. R., Benchmarking B cell epitope prediction: underperformance of existing methods Protein Science 2005 14 1 246 248
17. Mittelman A., Lucchese A., Sinha A. A., Kanduc D., Monoclonal and polyclonal humoral immune response to EC HER-2/neu peptides with low similarity to the host's proteome International Journal of Cancer 2002 98 5 741 747
18. Lucchese A., Mittelman A., Lin M.-S., Kanduc D., Sinha A. A., Epitope definition by proteomic similarity analysis: identification of the linear determinant of the anti-Dsg3 MAb 5H10 Journal of Translational Medicine 2004 2, article 43
19. Tiwari R., Geliebter J., Lucchese A., Mittelman A., Kanduc D., Computational peptide dissection of Melan-a/MART-1 oncoprotein antigenicity Peptides 2004 25 11 1865 1871
20. Mittelman A., Tiwari R., Lucchese G., Willers J., Dummer R., Kanduc D., Identification of monoclonal anti-HMW-MAA antibody linear peptide epitope by proteomic database mining Journal of Investigative Dermatology 2004 123 4 670 675
21. Dummer R., Mittelman A., Fanizzi F. P., Lucchese G., Willers J., Kanduc D., Non-self-discrimination as a driving concept in the identification of an immunodominant HMW-MAA epitopic peptide sequence by autoantibodies from melanoma cancer patients International Journal of Cancer 2004 111 5 720 726
22. Lucchese A., Willers J., Mittelman A., Kanduc D., Dummer R., Proteomic scan for tyrosinase peptide antigenic pattern in vitiligo and melanoma: role of sequence similarity and HLA-DR1 affinity Journal of Immunology 2005 175 10 7009 7020
23. Willers J., Lucchese A., Mittelman A., Dummer R., Kanduc D., Definition of anti-tyrosinase MAb T311 linear determinant by proteome-based similarity analysis Experimental Dermatology 2005 14 7 543 550
24. Stufano A., Kanduc D., Proteome-based epitopic peptide scanning along PSA Experimental and Molecular Pathology 2009 86 1 36 40
25. Kanduc D., Lucchese A., Mittelman A., Individuation of monoclonal anti-HPV16 E7 antibody linear peptide epitope by computational biology Peptides 2001 22 12 1981 1985
26. Kanduc D., Tessitore L., Lucchese G., Kusalik A., Farber E., Marincola F. M., Sequence uniqueness and sequence variability as modulating factors of human anti-HCV humoral immune response Cancer Immunology, Immunotherapy 2008 57 8 1215 1223
27. Lucchese G., Stufano A., Kanduc D., Proteome-guided search for influenza A B-cell epitopes FEMS Immunology and Medical Microbiology 2009 57 1 88 92
28. Kanduc D., Self-nonself peptides in the design of vaccines Current Pharmaceutical Design 2009 15 28 3283 3289
29. Peters B., Sidney J., Bourne P., The immune epitope database and analysis resource: from vision to blueprint PLoS Biology 2005 3 3, article e91
30. Blythe M. J., Zhang Q., Vaughan K., An analysis of the epitope knowledge related to Mycobacteria Immunome Research 2007 3 1, article 10
31. Chakhaiyar P., Nagalakshmi Y., Aruna B., Murthy K. J. R., Katoch V. M., Hasnain S. E., Regions of high antigenicity within the hypothetical PPE major polymorphic tandem repeat open-reading frame, Rv2608, show a differential humoral response and a low T cell response in various categories of patients with tuberculosis Journal of Infectious Diseases 2004 190 7 1237 1244
32. May A. C. W., Percent sequence identity: the need to be explicit Structure 2004 12 5 737 738
33. Oldstone M. B. A., Molecular mimicry and immune-mediated diseases FASEB Journal 1998 12 13 1255 1265
34. Lucchese G., Stufano A., Trost B., Kusalik A., Kanduc D., Peptidology: short amino acid modules in cell biology and immunology Amino Acids 2007 33 4 703 707
35. Wu C. W., Yeh L.-S., Huang H., The protein information resource Nucleic Acids Research 2003 31 1 345 347
36. Hussain R., Shahid F., Zafar S., Dojki M., Dockrell H. M., Immune profiling of leprosy and tuberculosis patients to 15-mer peptides of Mycobacterium leprae and M. tuberculosis GroES in a BCG vaccinated area: implications for development of vaccine and diagnostic reagents Immunology 2004 111 4 462 471
37. Chua-Intra B., Peerapakorn S., Davey N., T-cell recognition of mycobacterial GroES peptides in Thai leprosy patients and contacts Infection and Immunity 1998 66 10 4903 4909
38. Chua-Intra B., Ivanyi J., Hills A., Thole J., Moreno C., Vordermeier H. M., Predominant recognition of species-specific determinants of the GroES homologues from Mycobacterium leprae and M. tuberculosis Immunology 1998 93 1 64 72
39. Chua-Intra B., Wilkinson R. J., Ivanyi J., Selective T-cell recognition of the N-terminal peptide of GroES in tuberculosis Infection and Immunity 2002 70 3 1645 1647
40. Harboe M., Malin A. S., Dockrell H. S., B-cell epitopes and quantification of the ESAT-6 protein of Mycobacterium tuberculosis Infection and Immunity 1998 66 2 717 723
41. Elsaghier A., Lathigra R., Ivanyi J., Localisation of linear epitopes at the carboxy-terminal end of the mycobacterial 71kDa heat shock protein Molecular Immunology 1992 29 9 1153 1156
42. Spencer J. S., Kim H. J., Marques A. M., Comparative analysis of B- and T-cell epitopes of Mycobacterium leprae and Mycobacterium tuberculosis culture filtrate protein 10 Infection and Immunity 2004 72 6 3161 3170
43. Roche P. W., Feng C. G., Britton W. J., Human T-cell epitopes on the Mycobacterium tuberculosis secreted protein MPT64 Scandinavian Journal of Immunology 1996 43 6 662 670
44. Harris D. P., Vordermeier H.-M., Arya A., Bogdan K., Moreno C., Ivanyi J., Immunogenicity of peptides for B cells is not impaired by overlapping T-cell epitope topology Immunology 1996 88 3 348 354
45. Ashbridge K. R., Bckstrm B. T., Liu H.-X., Mapping of T helper cell epitopes by using peptides spanning the 19-kDa protein of Mycobacterium tuberculosis: evidence for unique and shared epitopes in the stimulation of antibody and delayed-type hypersensitivity responses Journal of Immunology 1992 148 7 2248 2255
46. Falla J. C., Parra C. A., Mendoza M., Identification of B- and T-cell epitopes within the MTP40 protein of Mycobacterium tuberculosis and their correlation with the disease course Infection and Immunity 1991 59 7 2265 2273
47. De Smet K. A. L., Vordermeier H. M., Ivanyi J., A versatile system for the production of recombinant chimeric peptides Journal of Immunological Methods 1994 177 1-2 243 250
48. Vordermeier H.-M., Harris D. P., Moreno C., Singh M., Ivanyi J., The nature of the immunogen determines the specificity of antibodies and T cells to selected peptides of the 38kDa mycobacterial antigen International Immunology 1995 7 4 559 566
49. Lpez-Vidal Y., de Len-Rosales S. P., Castan-Arreola M., Rangel-Frausto M. S., Melndez-Herrada E., Sada-Daz E., Response of IFN- and IgG to ESAT-6 and 38kDa recombinant proteins and their peptides from Mycobacterium tuberculosis in tuberculosis patients and asymptomatic household contacts may indicate possible early-stage infection in the latter Archives of Medical Research 2004 35 4 308 317
50. Shams H., Klucar P., Weis S. E., Characterization of a Mycobacterium tuberculosis peptide that is recognized by human CD 4 + and CD 8 + T cells in the context of multiple HLA alleles Journal of Immunology 2004 173 3 1966 1977
51. Mustafa A. S., Shaban F. A., Al-Attiyah R., Human Th1 cell lines recognize the Mycobacterium tuberculosis ESAT-6 antigen and its peptides in association with frequently expressed HLA class II molecules Scandinavian Journal of Immunology 2003 57 2 125 134
52. Harris D. P., Vordermeier H. M., Friscia G., Genetically permissive recognition of adjacent epitopes from the 19-kDa antigen of Mycobacterium tuberculosis by human and murine T cells Journal of Immunology 1993 150 11 5041 5050
53. Young D. B., The immune response to mycobacterial heat shock proteins Autoimmunity 1990 7 4 237 244
54. Shinnick T. M., Heat shock proteins as antigens of bacterial and parasitic pathogens Current Topics in Microbiology and Immunology 1991 167 145 160
55. Young D. B., Garbe T. R., Heat shock proteins and antigens of Mycobacterium tuberculosis Infection and Immunity 1991 59 9 3086 3093
56. Oseroff C., Peters B., Pasquetto V., Dissociation between epitope hierarchy and immunoprevalence in CD8 responses to vaccinia virus western reserve Journal of Immunology 2008 180 11 7193 7202
57. Winkler D. A., Burden F. R., Nonlinear predictive modeling of MHC class II-peptide binding using Bayesian neural networks Methods in Molecular Biology 2007 409 365 377
58. Harris D. P., Hill M., Vordermeier H.-M., Mutagenesis of an immunodominant Y cell epitope can affect recognition of different T and B determinants within the same antigen Molecular Immunology 1997 34 4 315 322
59. Rothbard J. B., Gefter M. L., Interactions between immunogenic peptides and MHC proteins Annual Review of Immunology 1991 9 527 565
60. Reddehase M. J., Rothbard J. B., Koszinowski U. H., A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes Nature 1989 337 6208 651 653
61. Hemmer B., Kondo T., Gran B., Minimal peptide length requirements for CD 4 + T cell clonesimplications for molecular mimicry and T cell survival International Immunology 2000 12 3 375 383
62. Niman H. L., Houghten R. A., Walker L. E., Generation of protein-reactive antibodies by short peptides is an event of high frequency: implications for the structural basis of immune recognition Proceedings of the National Academy of Sciences of the United States of America 1983 80 16 4949 4953
63. Schmidt W., Buschle M., Zauner W., Cell-free tumor antigen peptide-based cancer vaccines Proceedings of the National Academy of Sciences of the United States of America 1997 94 7 3262 3267
64. Gjertsen M. K., Bjorheim J., Saeterdal I., Myklebust J., Gaudernack G., Cytotoxic CD 4 + and CD 8 + T lymphocytes, generated by mutant p21-ras (12Val) peptide vaccination of a patient, recognize 12Val-dependent nested epitopes present within the vaccine peptide and kill autologous tumour cells carrying this mutation International Journal of Cancer 1997 72 5 784 790
65. Gritzapis A. D., Fridman A., Perez S. A., HER-2/neu (657-665) represents an immunogenic epitope of HER-2/neu oncoprotein with potent antitumor properties Vaccine 2009 28 1 162 170
66. Askelf P., Rodmalm K., Wrangsell G., Protective immunogenicity of two synthetic peptides selected from the amino acid sequence of Bordetella pertussis toxin subunit S1 Proceedings of the National Academy of Sciences of the United States of America 1990 87 4 1347 1351
67. Calvo-Calle J. M., Oliveira G. A., Watta C. O., Soverow J., Parra-Lopez C., Nardin E. H., A linear peptide containing minimal T- and B-cell epitopes of Plasmodium falciparum circumsporozoite protein elicits protection against transgenic sporozoite challenge Infection and Immunity 2006 74 12 6929 6939
68. Farsinejad K., Daneshpazhooh M., Sairafi H., Barzegar M., Mortazavizadeh M., Lupus vulgaris at the site of BCG vaccination: report of three cases Clinical and Experimental Dermatology 2009 34 5 e167 e169
69. Enserink M., Public health: in the HIV era, an old TB vaccine causes new problems Science 2007 318 5853 1059
70. Attia E., BCG vaccine-induced lupus vulgaris European Journal of Dermatology 2007 17 6 547 548
71. Hristea A., Neacsu A., Ion D. A., Streinu-Cercel A., Stniceanu F., BCG-related granulomatous hepatitis Pneumologia 2007 56 1 32 34
72. Mandavilli A., When the vaccine causes disease Nature Medicine 2007 13 3 274
73. Spratt A., Key T., Vivian A. J., Chronic anterior uveitis following bacille Calmette-Gurin vaccination: molecular mimicry in action? Journal of Pediatric Ophthalmology and Strabismus 2008 45 4 252 253
74. Kanduc D., Epitopic peptides with low similarity to the host proteome: towards biological therapies without side effects Expert Opinion on Biological Therapy 2009 9 1 45 53